U.S. Markets open in 2 hrs 46 mins

Three tech, three biotech companies that are top takeover targets in 2019

Jeff Reeves
Three tech, three biotech companies that are top takeover targets in 2019

Bristol-Myers Squibb (BMY) last week ponied up $74 billion, a 54% premium, for biotechnology heavyweight Celgene. Big Pharma needs the next generation of treatments to fuel future growth. Another massive purchase was IBM’s (IBM) $33 billion takeover of software firm Red Hat Inc. (RHT) The fact that Big Blue paid a premium of more than 60% in October, one of the worst months for stocks in recent memory, is proof that mega-cap technology companies aren’t afraid to shell out big bucks even amid talk of a tough stock market.